The impact of the COVID-19 pandemic and the changing landscape of CF on the cASPerCF trial: a real-world experience

Trials. 2024 Oct 2;25(1):645. doi: 10.1186/s13063-024-08510-1.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Humans
  • Pandemics
  • SARS-CoV-2
  • Treatment Outcome